Anti-Inflammatory Effects of Pioglitazone

NCT00722631 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Impaired Glucose Tolerance
Type 2 Diabetes Mellitus
Atherosclerosis

Interventions

DRUG: Pioglitazone
DRUG: Glimepiride

Sponsor

Kurume University